Fungal & Molecular Diagnostic Testing Services

The contract is for specialized microbiological and molecular diagnostic testing services focused on fungal pathogens, including fungal cultures, TSPOT-TB assays, antifungal susceptibility testing, and molecular identification of fungal organisms. These services are critical for accurate diagnosis and treatment guidance, particularly in complex or immunocompromised patient populations. The work must be performed in compliance with high-standard laboratory protocols to ensure reliable and timely results, supporting clinical decision-making within a defense health context. This is a subcontract under the Defense Health Agency Hcd West, part of the Department of Defense, with a NAICS code of 621512 indicating it pertains to medical and diagnostic laboratories. The solicitation was posted on July 9, 2026, and responses are due by July 24, 2026. The place of performance is not specified, indicating flexibility in location, but performance must meet Department of Defense requirements for quality, security, and timeliness. The contract does not specify a set-aside status, meaning it is open to all eligible subcontractors who can demonstrate the requisite expertise and capacity to deliver the required testing services.